S
HANALL BIOPHARMA
[Interim Report on Business Performance (Fair Disclosure)]
Search
Prev
Next
Search
Main Documents
Select
2023.01.20 Interim Report on Business Performance (Fair Disclosure)
Attachment Documents
Select
+Select Documents+
-Main Documents-
2023.01.20 Interim Report on Business Performance (Fair Disclosure)
Download
Print
Close
Index
☞ This disclosure is under the jurisdiction of [Korea Exchange’s Securities Market Headquarters].